Particularly, we hypothesized that the mutation-specific redistribution of myosin energetic states and abnormal SRX↔DRX equilibrium is one of the key mechanisms underlying the pathogenesis of HCM, RCM, or DCM, and successful therapy should target an anomalous SRX/DRX ratio. Here, MYH14 is linked to familial dilated cardiomyopathy.